Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erwin Dreesen

Showing results (61-70 of 105) with videos related to

Pageof 11
Sort By:
Clinical Pharmacokinetics|March 2, 2023
Insights into the Pharmacokinetics and Pharmacodynamics of Direct Oral Anticoagulants in Older Adults with Atrial Fibrillation: A Structured Narrative ReviewAngela Elma Edwina, Nada Dia, Erwin Dreesen, et al.
Frontiers in Pharmacology|June 30, 2020
Saliva for Precision Dosing of Antifungal Drugs: Saliva Population PK Model for Voriconazole Based on a Systematic ReviewHannah Yejin Kim, Anne-Grete Märtson, Erwin Dreesen, et al.
International Journal of Antimicrobial Agents|November 10, 2021
Prospective assessment of breakthrough infections and neurotoxicity and their association with cefepime trough concentrations in patients with febrile neutropeniaMatthias Gijsen, Britt Bekkers, Johan Maertens, et al.
Infection and Drug Resistance|January 17, 2022
Meropenem Target Attainment and Population Pharmacokinetics in Critically Ill Septic Patients with Preserved or Increased Renal FunctionMatthias Gijsen, Omar Elkayal, Pieter Annaert, et al.
Inflammatory Bowel Diseases|November 16, 2017
Antibodies Toward Vedolizumab Appear from the First Infusion Onward and Disappear Over TimeSumin Bian, Erwin Dreesen, Ho Tsun Tang, et al.
Antibiotics (Basel, Switzerland)|July 29, 2023
Isavuconazole Exposure in Critically Ill Patients Treated with Extracorporeal Membrane Oxygenation: Two Case Reports and a Narrative Literature ReviewBeatrijs Mertens, Omar Elkayal, Erwin Dreesen, et al.
Journal of Crohn'S & Colitis|March 2, 2019
Subcutaneous Absorption Contributes to Observed Interindividual Variability in Adalimumab Serum Concentrations in Crohn's Disease: A Prospective Multicentre StudyNiels Vande Casteele, Filip Baert, Sumin Bian, et al.
Neurogastroenterology and Motility|March 25, 2024
Do we perceive sensations inside and outside of our body differently? Perceptual, emotional, and behavioral differences between visceral and somatic sensation, discomfort, and painLivia Guadagnoli, Yannick Hoffert, Sofie Den Hond, et al.
The Journal of Antimicrobial Chemotherapy|June 3, 2024
Dosing of IV posaconazole to treat critically ill patients with invasive pulmonary aspergillosis: a population pharmacokinetics modelling and simulation studyOmar Elkayal, Beatrijs Mertens, Joost Wauters, et al.
Clinical Pharmacokinetics|March 27, 2024
Personalized Antifungal Therapy Through Model-Informed Precision Dosing of PosaconazoleAnouk M E Jansen, Kim Snijdelaar, Ron J Keizer, et al.
Pageof 11

Showing results (61-70 of 105) with videos related to

Sort By:
Pageof 11
Clinical Pharmacokinetics|March 2, 2023
Insights into the Pharmacokinetics and Pharmacodynamics of Direct Oral Anticoagulants in Older Adults with Atrial Fibrillation: A Structured Narrative ReviewAngela Elma Edwina, Nada Dia, Erwin Dreesen, et al.
Frontiers in Pharmacology|June 30, 2020
Saliva for Precision Dosing of Antifungal Drugs: Saliva Population PK Model for Voriconazole Based on a Systematic ReviewHannah Yejin Kim, Anne-Grete Märtson, Erwin Dreesen, et al.
International Journal of Antimicrobial Agents|November 10, 2021
Prospective assessment of breakthrough infections and neurotoxicity and their association with cefepime trough concentrations in patients with febrile neutropeniaMatthias Gijsen, Britt Bekkers, Johan Maertens, et al.
Infection and Drug Resistance|January 17, 2022
Meropenem Target Attainment and Population Pharmacokinetics in Critically Ill Septic Patients with Preserved or Increased Renal FunctionMatthias Gijsen, Omar Elkayal, Pieter Annaert, et al.
Inflammatory Bowel Diseases|November 16, 2017
Antibodies Toward Vedolizumab Appear from the First Infusion Onward and Disappear Over TimeSumin Bian, Erwin Dreesen, Ho Tsun Tang, et al.
Antibiotics (Basel, Switzerland)|July 29, 2023
Isavuconazole Exposure in Critically Ill Patients Treated with Extracorporeal Membrane Oxygenation: Two Case Reports and a Narrative Literature ReviewBeatrijs Mertens, Omar Elkayal, Erwin Dreesen, et al.
Journal of Crohn'S & Colitis|March 2, 2019
Subcutaneous Absorption Contributes to Observed Interindividual Variability in Adalimumab Serum Concentrations in Crohn's Disease: A Prospective Multicentre StudyNiels Vande Casteele, Filip Baert, Sumin Bian, et al.
Neurogastroenterology and Motility|March 25, 2024
Do we perceive sensations inside and outside of our body differently? Perceptual, emotional, and behavioral differences between visceral and somatic sensation, discomfort, and painLivia Guadagnoli, Yannick Hoffert, Sofie Den Hond, et al.
The Journal of Antimicrobial Chemotherapy|June 3, 2024
Dosing of IV posaconazole to treat critically ill patients with invasive pulmonary aspergillosis: a population pharmacokinetics modelling and simulation studyOmar Elkayal, Beatrijs Mertens, Joost Wauters, et al.
Clinical Pharmacokinetics|March 27, 2024
Personalized Antifungal Therapy Through Model-Informed Precision Dosing of PosaconazoleAnouk M E Jansen, Kim Snijdelaar, Ron J Keizer, et al.
Pageof 11